Q3 2022 13F Holders as of 9/30/2022
-
Type / Class
-
Equity / SPON ADS
-
Number of holders
-
61
-
Total shares
-
49.2M
-
Shares change
-
-1.51M
-
Total reported value, excl. options
-
$105M
-
Value change
-
-$3.35M
-
Number of buys
-
20
-
Number of sells
-
-21
-
Price
-
$2.14
Significant Holders of Autolus Therapeutics plc - SPON ADS (AUTL) as of Q3 2022
63 filings reported holding AUTL - Autolus Therapeutics plc - SPON ADS as of Q3 2022.
Autolus Therapeutics plc - SPON ADS (AUTL) has 61 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 49.2M shares
.
Largest 10 shareholders include Blackstone Inc. (18M shares), Syncona Portfolio Ltd (7.35M shares), Nantahala Capital Management, LLC (5.22M shares), Frazier Life Sciences Management, L.P. (3.75M shares), TFG Asset Management GP Ltd (3.04M shares), SCHRODER INVESTMENT MANAGEMENT GROUP (1.67M shares), Pendal Group Ltd (1.37M shares), CITADEL ADVISORS LLC (1.14M shares), Alphabet Inc. (698K shares), and Capital World Investors (625K shares).
This table shows the top 61 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.